---
figid: PMC2709717__PPAR2009-830501.001
figlink: /pmc/articles/PMC2709717/figure/fig1/
number: F1
caption: 'The IGF system: receptors, ligands, and signaling pathways.  (a)  Schematic
  representation of the major receptors and ligands involved in the IGF system.  Insulin
  receptor isoforms (IR-A or IR-B) binds insulin with high affinity, while IGF-I receptor
  (IGF-IR) binds IGF-I and IGF-II (left). In cells expressing both IR and IGF-IR,
  IR hemireceptors may heterodimerize with IGF-IR hemireceptors, leading to the formation
  of hybrid IR/IGF-IRs (HRs), which bind IGF-I and IGF-II with high affinity and insulin
  with a much lower affinity (right). (b) The IGF system signaling pathways. Schematic
  representation of the two major signaling pathways involved in IGF system. IGF-I,
  IGF-II, and insulin bind to their cognate receptors, leading to the activation of
  the PI3K/Akt/mTOR pathway and of the Ras/Raf-1/MEK/ERK pathway.'
pmcid: PMC2709717
papertitle: 'PPAR-Î³ Agonists and Their Effects on IGF-I Receptor Signaling: Implications
  for Cancer.'
reftext: A. Belfiore, et al. PPAR Res. 2009;2009:830501.
pmc_ranked_result_index: '15144'
pathway_score: 0.8929633
filename: PPAR2009-830501.001.jpg
figtitle: 'IGF system: receptors, ligands, and signaling pathways'
year: '2009'
organisms:
- Mus musculus
- Human immunodeficiency virus 1
- Mouse mammary tumor virus
- Homo sapiens
- Bos taurus
ndex: 021839d1-deaa-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC2709717__PPAR2009-830501.001.html
  '@type': Dataset
  description: 'The IGF system: receptors, ligands, and signaling pathways.  (a)  Schematic
    representation of the major receptors and ligands involved in the IGF system.  Insulin
    receptor isoforms (IR-A or IR-B) binds insulin with high affinity, while IGF-I
    receptor (IGF-IR) binds IGF-I and IGF-II (left). In cells expressing both IR and
    IGF-IR, IR hemireceptors may heterodimerize with IGF-IR hemireceptors, leading
    to the formation of hybrid IR/IGF-IRs (HRs), which bind IGF-I and IGF-II with
    high affinity and insulin with a much lower affinity (right). (b) The IGF system
    signaling pathways. Schematic representation of the two major signaling pathways
    involved in IGF system. IGF-I, IGF-II, and insulin bind to their cognate receptors,
    leading to the activation of the PI3K/Akt/mTOR pathway and of the Ras/Raf-1/MEK/ERK
    pathway.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PIK3R3
  - PIK3R4
  - PIK3R6
  - IRS2
  - MAP2K1
  - IGF1
  - PIK3R5
  - IRS4
  - ARAF
  - IGF2
  - AKT2
  - MAPK1
  - RAF1
  - PIK3CA
  - IGF1R
  - BRAF
  - MAPK3
  - MAP2K2
  - PIK3CD
  - TSC1
  - IRS1
  - AGFG1
  - TSC2
  - KRAS
  - AKT1
  - PIK3CB
  - AKT3
  - PIK3CG
  - NRAS
  - HRAS
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
genes:
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: IGF-IR/IRs/HRs
  symbol: IRS
  source: bioentities_symbol
  hgnc_symbol: IRS2
  entrez: '8660'
- word: (MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: IGF-I
  symbol: IGF-I
  source: hgnc_alias_symbol
  hgnc_symbol: IGF1
  entrez: '3479'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: IGF-IR/IRs/HRs
  symbol: IRS
  source: bioentities_symbol
  hgnc_symbol: IRS4
  entrez: '8471'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: IGF-II
  symbol: IGF-II
  source: hgnc_alias_symbol
  hgnc_symbol: IGF2
  entrez: '3481'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: IGF-IR
  symbol: IGFIR
  source: hgnc_alias_symbol
  hgnc_symbol: IGF1R
  entrez: '3480'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: (MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: TSC1/2
  symbol: TSC1
  source: hgnc_symbol
  hgnc_symbol: TSC1
  entrez: '7248'
- word: IGF-IR/IRs/HRs
  symbol: IRS
  source: bioentities_symbol
  hgnc_symbol: IRS1
  entrez: '3667'
- word: HR-B
  symbol: HRB
  source: hgnc_prev_symbol
  hgnc_symbol: AGFG1
  entrez: '3267'
- word: TSC1/2
  symbol: TSC2
  source: hgnc_symbol
  hgnc_symbol: TSC2
  entrez: '7249'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Cardiomyopathy
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
figid_alias: PMC2709717__F1
redirect_from: /figures/PMC2709717__F1
figtype: Figure
---
